+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Drug Discovery Market by Application, Technology, Therapeutic Area, End User, Deployment Mode - Global Forecast 2025-2030- Product Image
Artificial Intelligence in Drug Discovery Market by Application, Technology, Therapeutic Area, End User, Deployment Mode - Global Forecast 2025-2030- Product Image
Sale

Artificial Intelligence in Drug Discovery Market by Application, Technology, Therapeutic Area, End User, Deployment Mode - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995111
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Artificial Intelligence in Drug Discovery Market is undergoing significant transformation, reshaping processes from early-stage research through clinical development. Senior leaders seeking streamlined drug discovery and data-driven decision-making are turning to AI-enabled solutions for a strategic edge.

Market Snapshot: Artificial Intelligence in Drug Discovery

The Artificial Intelligence in Drug Discovery Market grew from USD 1.35 billion in 2024 to USD 1.74 billion in 2025. It is expected to continue growing at a CAGR of 27.49%, reaching USD 5.83 billion by 2030. This consistent upward trend reflects accelerated investment, expanding technological capabilities, and increasing industry reliance on predictive analytics for drug research and development efficiency.

Scope & Segmentation: In-Depth Market Coverage

  • Applications: ADMET and toxicology prediction, clinical trial optimization, hit identification, lead optimization, protein structure prediction
  • ADMET and Toxicology Prediction: Pharmacodynamics prediction, pharmacokinetics prediction, toxicity prediction
  • Clinical Trial Optimization: Patient recruitment, trial design optimization
  • Hit Identification: High throughput screening, in silico target validation, virtual screening
  • Lead Optimization: De novo drug design, quantitative structure-activity relationship, structure-based drug design
  • Protein Structure Prediction: Ab initio modeling, homology modeling, molecular dynamics simulation
  • Technologies: Computer vision, deep learning, machine learning, natural language processing
  • Therapeutic Areas: Cardiovascular diseases, central nervous system conditions, infectious diseases, oncology
  • End Users: Academic and research institutes, biotechnology companies, contract research organizations, pharmaceutical companies
  • Deployment Modes: Cloud based, hybrid, on premises
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
  • Companies Analyzed: Schrödinger, Inc., Recursion Pharmaceuticals, Inc., Exscientia plc, Valo Health, Inc., Atomwise, Inc., Insilico Medicine, Inc., BenevolentAI Limited, Cloud Pharmaceuticals, Inc., Healx Limited, Microsoft Corporation

Key Takeaways for Senior Decision-Makers

  • Artificial intelligence now underpins multiple phases in drug discovery, supporting both predictive modeling and accelerated candidate screening.
  • Machine learning, deep learning, and computer vision are increasingly critical for interpreting complex biological and chemical datasets.
  • Industry adoption is not limited to large pharmaceutical firms; start-ups and contract research organizations are expanding AI-driven innovation across the ecosystem.
  • Federated learning and collaborative platforms balance data privacy with efficient knowledge sharing, helping organizations leverage external expertise without compromising IP.
  • Cloud deployment models enable scalability and flexibility, while hybrid and on-premises installations support specific security or compliance needs.
  • Regional strategies vary, with North American and Asia-Pacific organizations emphasizing high-performance computing investments and European stakeholders driving regulatory harmonization and collaborative pilot projects.

Tariff Impact: New Dynamics in Cost and Collaboration

Recent United States tariff measures on laboratory reagents, hardware, and computing equipment have added operational complexity for drug discovery organizations. As production and research costs rise, firms are adapting supply chain strategies, shifting manufacturing to favorable locations, and increasingly entering cross-border collaborations. Increased regulatory requirements for compliance have driven renewed focus on local sourcing and digital procurement solutions, shaping a more resilient, agile ecosystem in response to evolving trade barriers.

Methodology & Data Sources

This report is grounded in both primary expert interviews and comprehensive secondary research, including peer-reviewed publications, patent analysis, and validation workshops with independent industry specialists. Data triangulation ensures robust, actionable insights relevant to strategic planning needs.

Why This Report Matters

  • Supports executive decisions in technology investments and geographic expansion by providing actionable segmentation and competitor benchmarking.
  • Enables timely identification of partnership and innovation opportunities across therapeutic domains and end-user types.

Conclusion

Artificial intelligence is redefining value creation in drug discovery, driving operational efficiency and paving the way for strategic advancements. Stakeholders embracing collaborative, data-centric approaches are well positioned to realize benefits from emerging technologies and shifting global dynamics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advanced generative AI models accelerating de novo small molecule design and synthesis planning
5.2. Integration of multi-omics datasets with deep learning for precision target identification in oncology drug discovery
5.3. Implementation of AI-driven predictive ADMET modeling to reduce late-stage clinical trial failures
5.4. Deployment of reinforcement learning algorithms to optimize antibody design and therapeutic efficacy profiles
5.5. Adoption of cloud-native AI platforms for scalable virtual screening and collaborative research workflows
5.6. Use of real-world evidence and AI analytics for rapid drug repurposing in response to emerging health crises
5.7. Strategic partnerships between biopharma and tech giants to co-develop AI-powered drug discovery pipelines
5.8. Application of federated learning frameworks to train AI models on distributed proprietary datasets securely
5.9. Regulatory initiatives and guidelines shaping AI validation and transparency in drug discovery processes
5.10. Incorporation of explainable AI techniques to enhance interpretability and regulatory acceptance of predictions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Intelligence in Drug Discovery Market, by Application
8.1. Introduction
8.2. ADMET And Toxicology Prediction
8.2.1. Pharmacodynamics Prediction
8.2.2. Pharmacokinetics Prediction
8.2.3. Toxicity Prediction
8.3. Clinical Trial Optimization
8.3.1. Patient Recruitment
8.3.2. Trial Design Optimization
8.4. Hit Identification
8.4.1. High Throughput Screening
8.4.2. In Silico Target Validation
8.4.3. Virtual Screening
8.5. Lead Optimization
8.5.1. De Novo Drug Design
8.5.2. Quantitative Structure Activity Relationship
8.5.3. Structure Based Drug Design
8.6. Protein Structure Prediction
8.6.1. Ab Initio Modeling
8.6.2. Homology Modeling
8.6.3. Molecular Dynamics Simulation
9. Artificial Intelligence in Drug Discovery Market, by Technology
9.1. Introduction
9.2. Computer Vision
9.3. Deep Learning
9.4. Machine Learning
9.5. Natural Language Processing
10. Artificial Intelligence in Drug Discovery Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiovascular Diseases
10.3. Central Nervous System
10.4. Infectious Diseases
10.5. Oncology
11. Artificial Intelligence in Drug Discovery Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Biotechnology Companies
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
12. Artificial Intelligence in Drug Discovery Market, by Deployment Mode
12.1. Introduction
12.2. Cloud Based
12.3. Hybrid
12.4. On Premises
13. Americas Artificial Intelligence in Drug Discovery Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Artificial Intelligence in Drug Discovery Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Artificial Intelligence in Drug Discovery Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Schrödinger, Inc.
16.3.2. Recursion Pharmaceuticals, Inc.
16.3.3. Exscientia plc
16.3.4. Valo Health, Inc.
16.3.5. Atomwise, Inc.
16.3.6. Insilico Medicine, Inc.
16.3.7. BenevolentAI Limited
16.3.8. Cloud Pharmaceuticals, Inc.
16.3.9. Healx Limited
16.3.10. Microsoft Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: RESEARCHAI
FIGURE 26. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: RESEARCHSTATISTICS
FIGURE 27. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: RESEARCHCONTACTS
FIGURE 28. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACODYNAMICS PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACODYNAMICS PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACOKINETICS PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACOKINETICS PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TOXICITY PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TOXICITY PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PATIENT RECRUITMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PATIENT RECRUITMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TRIAL DESIGN OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TRIAL DESIGN OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IN SILICO TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IN SILICO TARGET VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DE NOVO DRUG DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DE NOVO DRUG DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DRUG DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DRUG DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY AB INITIO MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY AB INITIO MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HOMOLOGY MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HOMOLOGY MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MOLECULAR DYNAMICS SIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MOLECULAR DYNAMICS SIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COMPUTER VISION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLOUD BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HYBRID, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ON PREMISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 144. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 145. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 152. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 153. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 156. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 157. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 160. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET AND TOXICOLOGY PREDICTION, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITE

Samples

Loading
LOADING...

Companies Mentioned

  • Schrödinger, Inc.
  • Recursion Pharmaceuticals, Inc.
  • Exscientia plc
  • Valo Health, Inc.
  • Atomwise, Inc.
  • Insilico Medicine, Inc.
  • BenevolentAI Limited
  • Cloud Pharmaceuticals, Inc.
  • Healx Limited
  • Microsoft Corporation

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.83 Billion
Compound Annual Growth Rate27.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Drug Discovery Services Market by Service Type (Adme Dmpk Testing, Biomarker Discovery, Compound Synthesis & Scale Up), Technology (Computational Biology, Flow Cytometry, High Throughput Screening), Molecule Type, End User, Therapeutic Area - Global Forecast 2025-2030 - Product Image

Drug Discovery Services Market by Service Type (Adme Dmpk Testing, Biomarker Discovery, Compound Synthesis & Scale Up), Technology (Computational Biology, Flow Cytometry, High Throughput Screening), Molecule Type, End User, Therapeutic Area - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Drug Discovery Informatics Market by Component (Services, Software), Application (Admet Prediction, Lead Discovery, Molecular Modeling Simulation), Deployment, End User, Therapeutic Area - Global Forecast 2025-2030 - Product Image

Drug Discovery Informatics Market by Component (Services, Software), Application (Admet Prediction, Lead Discovery, Molecular Modeling Simulation), Deployment, End User, Therapeutic Area - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Generative Artificial Intelligence (AI) in Drug Discovery Market Report 2025 - Product Image

Generative Artificial Intelligence (AI) in Drug Discovery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease Understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029 - Product Image

Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease Understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029

  • Report
  • 478 Pages
  • Global
From
Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report - Product Image

Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report

  • Report
  • 219 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.